Combined modality therapy in pancreatic adenocarcinoma: Review and updates on a controversial issue Journal Article
| Authors: | Cavalcante, L.; Kelsen, D. P.; Yu, K. H. |
| Article Title: | Combined modality therapy in pancreatic adenocarcinoma: Review and updates on a controversial issue |
| Abstract: | Due to its extremely high mortality rates, strong efforts continue to be made to develop new therapies in the treatment of pancreatic adenocarcinoma. The use of combined modality chemoradiotherapy for the treatment of pancreatic adenocarcinoma remains an approach with both promise and controversy. This article reviews the conflicting data with regards to role of combined modality therapy in pancreatic adenocarcinoma and provides an update on current studies in the field. |
| Keywords: | review; gemcitabine; chemotherapy; radiation; radiotherapy; pancreatic adenocarcinoma; chemoradiotherapy; concurrent; phase-iii trial; randomized-trial; cooperative-oncology-group; cancer |
| Journal Title: | Current Pharmaceutical Design |
| Volume: | 20 |
| Issue: | 42 |
| ISSN: | 1381-6128 |
| Publisher: | Bentham Science Publishers |
| Date Published: | 2014-01-01 |
| Start Page: | 6697 |
| End Page: | 6701 |
| Language: | English |
| ACCESSION: | WOS:000343998200015 |
| PROVIDER: | wos |
| PUBMED: | 25341941 |
| Notes: | Article -- Source: Wos |
